What to watch with Pharmakogenetik Medicheck and longevity?

The Pharmakogenetik Medicheck analyzes genetic variants affecting drug metabolism (e.g., CYP2D6, CYP2C19, VKORC1). For longevity, the key benefit is optimizing medication to reduce side effects and chronic stress, indirectly supporting healthspan. However, this test is not a direct longevity marker. Beware of overblown claims: many drug-gene interactions are well-evidenced (e.g., for antidepressants, anticoagulants), but evidence for direct lifespan extension is lacking. Lifestyle factors like diet, exercise, and environment matter far more. Results should be interpreted by a physician or pharmacist, not by consumers alone. The test can be useful if you take regular medications, but not as a standalone longevity strategy.